{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T20:30:20Z","timestamp":1783629020877,"version":"3.55.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:00:00Z","timestamp":1620950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["016.116.017"],"award-info":[{"award-number":["016.116.017"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["016.186.364"],"award-info":[{"award-number":["016.186.364"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["2016T060"],"award-info":[{"award-number":["2016T060"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001674","name":"Fondation Leducq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001674","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011097","name":"CARIM School for Cardiovascular Diseases, Universiteit Maastricht","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011878","name":"Vlaamse regering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011878","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p><jats:bold>Background and aims:<\/jats:bold> Atherosclerosis is an important cause of clinical cardiovascular events. Atherosclerotic plaques are hypoxic, and reoxygenation improves plaque phenotype. Central players in hypoxia are hypoxia inducible factors (HIF) and their regulators, HIF-prolyl hydroxylase (PHD) isoforms 1, 2, and 3. PHD inhibitors, targeting all three isoforms, are used to alleviate anemia in chronic kidney disease. Likewise, whole-body PHD1 and PHD2ko ameliorate hypercholesterolemia and atherogenesis. As the effect of whole-body PHD3 is unknown, we investigated the effects of germline whole-body PHD3ko on atherosclerosis.<\/jats:p><jats:p><jats:bold>Approach and Results:<\/jats:bold> To initiate hypercholesterolemia and atherosclerosis low-density lipoprotein receptor knockout (LDLrko) and PHD3\/LDLr double knockout (PHD3dko), mice were fed a high-cholesterol diet. Atherosclerosis and hypoxia marker pimonidazole were analyzed in aortic roots and brachiocephalic arteries. In contrast to earlier reports on PHD1- and PHD2-deficient mice, a small elevation in the body weight and an increase in the plasma cholesterol and triglyceride levels were observed after 10 weeks of diet. Dyslipidemia might be explained by an increase in hepatic mRNA expression of Cyp7a1 and fatty acid synthase, while lipid efflux of PHD3dko macrophages was comparable to controls. Despite dyslipidemia, plaque size, hypoxia, and phenotype were not altered in the aortic root or in the brachiocephalic artery of PHD3dko mice. Additionally, PHD3dko mice showed enhanced blood hematocrit levels, but no changes in circulating, splenic or lymphoid immune cell subsets.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Here, we report that whole-body PHD3dko instigated an unfavorable lipid profile and increased hematocrit, in contrast to other PHD isoforms, yet without altering atherosclerotic plaque development.<\/jats:p>","DOI":"10.3389\/fcell.2021.664258","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:55:05Z","timestamp":1620968105000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Whole-Body Prolyl Hydroxylase Domain (PHD) 3 Deficiency Increased Plasma Lipids and Hematocrit Without Impacting Plaque Size in Low-Density Lipoprotein Receptor Knockout Mice"],"prefix":"10.3389","volume":"9","author":[{"given":"Jasper A. F.","family":"Demandt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"van Kuijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Theelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Marsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean P.","family":"Heffron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Carmeliet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik A. L.","family":"Biessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith C.","family":"Sluimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,5,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1161\/atvbaha.116.307830","article-title":"Hypoxia-Inducible Factor-1alpha Expression in Macrophages Promotes Development of Atherosclerosis.","volume":"36","author":"Aarup","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/nu10060760","article-title":"Molecular Pathways Underlying Cholesterol Homeostasis.","volume":"10","author":"Afonso","year":"2018","journal-title":"Nutrients"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1161\/hypertensionaha.115.05886","article-title":"Endothelial Hypoxia-Inducible Factor-1alpha Promotes Atherosclerosis and Monocyte Recruitment by Upregulating MicroRNA-19a.","volume":"66","author":"Akhtar","year":"2015","journal-title":"Hypertension"},{"key":"B4","doi-asserted-by":"publisher","first-page":"38458","DOI":"10.1074\/jbc.m406026200","article-title":"Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor.","volume":"279","author":"Appelhoff","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/jcb.20067","article-title":"Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors.","volume":"92","author":"Aprelikova","year":"2004","journal-title":"J. Cell Biochem."},{"key":"B6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ng.2007.62","article-title":"Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism.","volume":"40","author":"Aragones","year":"2008","journal-title":"Nat. Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"472142","DOI":"10.1101\/472142","article-title":"Lower hemoglobin levels associate with lower body mass index and healthier metabolic profile.","author":"Auvinen","year":"2018","journal-title":"bioRxiv"},{"key":"B8","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1161\/atvbaha.108.183319","article-title":"HIF-1alpha overexpression and experimental murine atherosclerosis.","volume":"29","author":"Ben-Shoshan","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"4082","DOI":"10.1093\/emboj\/cdg392","article-title":"prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia.","volume":"22","author":"Berra","year":"2003","journal-title":"EMBO J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/nejmoa1901713","article-title":"Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis.","volume":"381","author":"Chen","year":"","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa1813599","article-title":"Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis.","volume":"381","author":"Chen","year":"","journal-title":"N. Engl. J. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.atherosclerosis.2014.01.048","article-title":"Local inhibition of hypoxia-inducible factor reduces neointima formation after arterial injury in ApoE-\/- mice.","volume":"233","author":"Christoph","year":"2014","journal-title":"Atherosclerosis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1161\/atvbaha.116.306874","article-title":"Do the Apoe-\/- and Ldlr-\/- Mice Yield the Same Insight on Atherogenesis?.","volume":"36","author":"Getz","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1172\/jci117179","article-title":"Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice.","volume":"93","author":"Ishibashi","year":"1994","journal-title":"J. Clin. Invest."},{"key":"B15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pharmthera.2017.09.003","article-title":"Hypoxia inducible factor as a therapeutic target for atherosclerosis.","volume":"183","author":"Jain","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"B16","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1161\/01.hyp.0000148304.33869.ee","article-title":"Early life factors and blood pressure at age 31 years in the 1966 northern Finland birth cohort.","volume":"44","author":"Jarvelin","year":"2004","journal-title":"Hypertension"},{"key":"B17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway.","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol. Cell"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1182\/blood-2010-02-270322","article-title":"Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia.","volume":"116","author":"Kapitsinou","year":"2010","journal-title":"Blood"},{"key":"B19","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.redox.2017.07.004","article-title":"BNIP3 induction by hypoxia stimulates FASN-dependent free fatty acid production enhancing therapeutic potential of umbilical cord blood-derived human mesenchymal stem cells.","volume":"13","author":"Lee","year":"2017","journal-title":"Redox Biol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.bbrc.2016.03.058","article-title":"Prolyl hydroxylase 3 overexpression accelerates the progression of atherosclerosis in ApoE-\/- mice.","volume":"473","author":"Liu","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1093\/eurheartj\/ehw156","article-title":"Deficiency of the oxygen sensor prolyl hydroxylase 1 attenuates hypercholesterolaemia, atherosclerosis, and hyperglycaemia.","volume":"37","author":"Marsch","year":"2016","journal-title":"Eur. Heart J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/atvbaha.114.304023","article-title":"Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis.","volume":"34","author":"Marsch","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1159\/000464476","article-title":"Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease.","volume":"45","author":"Martin","year":"2017","journal-title":"Am. J. Nephrol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.cell.2009.01.020","article-title":"Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization.","volume":"136","author":"Mazzone","year":"2009","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5729","DOI":"10.1128\/mcb.00331-09","article-title":"A feedback loop involving the Phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo.","volume":"29","author":"Minamishima","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/cells8030214","article-title":"Hypoxia-Inducible Factors and the Regulation of Lipid Metabolism.","volume":"8","author":"Mylonis","year":"2019","journal-title":"Cells"},{"key":"B27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1161\/01.atv.14.1.133","article-title":"ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.","volume":"14","author":"Nakashima","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2019.00046","article-title":"Mouse Models for Atherosclerosis Research-Which Is My Line?.","volume":"6","author":"Oppi","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/0092-8674(92)90362-g","article-title":"Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.","volume":"71","author":"Plump","year":"1992","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.2337\/db14-0472","article-title":"HIF prolyl 4-hydroxylase-2 inhibition improves glucose and lipid metabolism and protects against obesity and metabolic dysfunction.","volume":"63","author":"Rahtu-Korpela","year":"2014","journal-title":"Diabetes"},{"key":"B31","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1161\/atvbaha.115.307136","article-title":"Hypoxia-Inducible Factor Prolyl 4-Hydroxylase-2 Inhibition Protects Against Development of Atherosclerosis.","volume":"36","author":"Rahtu-Korpela","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/ije\/dym225","article-title":"Cohort profile: the cardiovascular risk in Young Finns Study.","volume":"37","author":"Raitakari","year":"2008","journal-title":"Int. J. Epidemiol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1128\/mcb.01441-13","article-title":"Loss of von Hippel-Lindau protein (VHL) increases systemic cholesterol levels through targeting hypoxia-inducible factor 2alpha and regulation of bile acid homeostasis.","volume":"34","author":"Ramakrishnan","year":"2014","journal-title":"Mol. Cell Biol."},{"key":"B34","article-title":"Groups at risk in low birth weight infants and perinatal mortality.","volume":"193","author":"Rantakallio","year":"1969","journal-title":"Acta Paediatr. Scand."},{"key":"B35","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bbcan.2018.07.002","article-title":"Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors.","volume":"1870","author":"Samanta","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Cancer."},{"key":"B36","doi-asserted-by":"publisher","first-page":"3133","DOI":"10.1182\/blood-2004-05-1695","article-title":"HIF-2alpha regulates murine hematopoietic development in an erythropoietin-dependent manner.","volume":"105","author":"Scortegagna","year":"2005","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1152\/physiolgenomics.00076.2007","article-title":"Dead or alive: gene expression profiles of advanced atherosclerotic plaques from autopsy and surgery.","volume":"30","author":"Sluimer","year":"2007","journal-title":"Physiol. Genomics"},{"key":"B38","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/circresaha.115.306256","article-title":"Macrophage Phenotype and Function in Different Stages of Atherosclerosis.","volume":"118","author":"Tabas","year":"2016","journal-title":"Circ. Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"8336","DOI":"10.1128\/mcb.00425-06","article-title":"Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2.","volume":"26","author":"Takeda","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/nm.3294","article-title":"Cross-talk between hypoxia and insulin signaling through Phd3 regulates hepatic glucose and lipid metabolism and ameliorates diabetes.","volume":"19","author":"Taniguchi","year":"2013","journal-title":"Nat. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1172\/jci43273","article-title":"Prolyl hydroxylase 3 (PHD3) is essential for hypoxic regulation of neutrophilic inflammation in humans and mice.","volume":"121","author":"Walmsley","year":"2011","journal-title":"J. Clin. Invest."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1096\/fj.04-1640fje","article-title":"Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells.","volume":"18","author":"Warnecke","year":"2004","journal-title":"FASEB J."},{"key":"B43","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1161\/circulationaha.117.032636","article-title":"Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.","volume":"138","author":"Westerterp","year":"2018","journal-title":"Circulation"},{"key":"B44","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1126\/science.1411543","article-title":"Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E.","volume":"258","author":"Zhang","year":"1992","journal-title":"Science"}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.664258\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:55:12Z","timestamp":1620968112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2021.664258\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,14]]},"references-count":44,"alternative-id":["10.3389\/fcell.2021.664258"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2021.664258","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,14]]},"article-number":"664258"}}